Syntegon reports H1 2025 EBITDA higher by 41% to €127 million
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
This PSD-3, the first pharmaceutical spray dryer built by GEA for OEB-5 products, sets new standards for high-containment pharmaceutical spray drying
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The company is bringing precision therapies for gynaecological cancers
This project shall be implemented through incorporation of a new joint venture company in Zambia
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Subscribe To Our Newsletter & Stay Updated